Netanasvir Phosphate

磷酸萘坦司韦

Report date: 2025/10/30 16:14:28
NME

Base Information

Drug NameNetanasvir Phosphate
Drug Alias Name磷酸安泰他韦Antaitasvir Phosphate东卫卓HEC-74647-PA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNonstructural protein 5A inhibitors
TargetsNonstructural protein 5A
Therapy Area/IndicationsHepatitis C, ChronicHepatitis C
Global Approved IndicationsHepatitis C, Chronic
Approved Indications in ChinaHepatitis C, Chronic
Original Approved Country/TerritoryMainland China
Original Approved Date2025/02/08
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGuangdong Dongyangguang Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSunshine Lake Pharma Co LtdGuangdong Dongyangguang Pharmaceutical Co Ltd
Inactive CompaniesYichang Hec Changjiang Pharmaceutical Co Ltd
Active IndicationsHepatitis C, ChronicHepatitis C
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A